ACTM-838 / Actym Therap 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ACTM-838 / Actym Therap
ACTM-838-01, NCT06336148: A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors

Recruiting
1
35
RoW
ACTM-838
Actym Therapeutics, Inc.
Solid Tumor
01/26
07/26

Download Options